Amit Ahuja
Gastroenterology · Alexandria, LANPI 1528061959
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,110 and has fallen 88.0% since, to $133 in 2025. That places this record below the midpoint for gastroenterology clinicians in LA, where the typical reported total is $3,631.
Across 214 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$658
- Takeda Pharmaceuticals U.S.A., Inc.$615
- Pfizer$508
- Johnson & Johnson$441
- AbbVie$225
- Ferring Pharmaceuticals Inc.$141
- plus $944 from 18 others
What the payments were for
- Food & beverage$3,41697%
- Education$1173%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 65 | $658 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $615 |
| Pfizer | 29 | $508 |
| Johnson & Johnson(3 entities) | 17 | $441 |
| AbbVie(2 entities) | 18 | $225 |
| Ferring Pharmaceuticals Inc. | 2 | $141 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Ironwood Pharmaceuticals, Inc | 8 | $120 |
| Penumbra, Inc. | 1 | $107 |
| Bard Peripheral Vascular, Inc. | 5 | $95 |
| Merck | 7 | $94 |
| Calliditas Therapeutics US Inc. | 2 | $38 |
| Cumberland Pharmaceuticals, Inc. | 2 | $36 |
| Braintree Laboratories, Inc. | 2 | $30 |
| Redhill Biopharma Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Medtronic | 1 | $20 |
| Microvention, Inc. | 1 | $18 |
| UCB, Inc. | 1 | $16 |
| Shionogi Inc | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,533 in reported general payments places this provider in the 45th percentile of 254 gastroenterology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 29 | $287 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Alexandria
- Maury MorrisonAlexandria$15K
- Jill VidrineAlexandria$9K
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
- Gia LandryBaton Rouge$511K
- Charles MonierThibodaux$448K
- Nathaniel RanneyCovington$392K
- Georges CatinisMetairie$346K
- Humberto AguilarShreveport$313K
- Sarah GloverNew Orleans$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.